Introduction
Hepatitis B Viral (HBV) infection is a public health problem due to its high morbidity and mortality. Globally, about two billion people have been infected with 350 million developing chronic infection (Merrill and Hunter, 2011) . Furthermore, an estimated 600,000 people die from HBV associated diseases annually (Ott et al., 2012) . Sub-Saharan Africa and East Asia have the highest prevalence of HBV with 5 to 10% of the adult population being infected (Ott et al., 2012) .
The clinical outcome of HBV infection is strongly linked with the host immune response to the infection (Khan et al., 2011) . Cytokines, soluble short lived proteins secreted by T lymphocytes and other immune and non-immune cells play important roles in HBV pathogenesis and the host response (Koziel, 1999) . Th1 cytokines such as interleukin-12 (IL-12), tumour necrosis factoralpha (TNF-α) and interferon-gamma (IFN-γ) have been directly or indirectly shown to inhibit HBV replication and hence viral clearance whilst Th2 cytokine interleukin-4(IL-4) and immune suppressive cytokine, interleukin-10 (IL-10) are thought to facilitate viral persistence and development of chronic infection (Falasca et al., 2006) . Traditionally, the diagnosis and monitoring of HBV infections are based on virological markers of HBV and liver function tests (Das et al., 2012) . However, mutations that occur in the HBV genome may result in non-secretion of HBsAg and HBeAg. Hence the use of these viral markers as diagnostic markers may result in discordant results at certain times (Pan and Zhang, 2005; Chevaliez and Pawlotsky, 2008) therefore the need for alternative diagnostic markers for classifying the various stage of HBV infections.
Cytokines have been shown to play major role in HBV associated liver damage (Yan et al., 1999; Blankson et al., 2005) , cancers (Wong et al., 2009) and the treatment response to various antiviral agents (Hall and Cash, 2012) . However, the diagnostic performance and disease pattern of Th1 and Th2 cytokines in acute HBV, HBV recovery, HBeAg positive CHB and HBeAg negative CHB have not been examined extensively. In addition, variations in host genetic immune response make it imperative to study the balance between immune suppressive, Th1 and Th2 cytokines among the Ghanaian populace. It is against this background that this study for the first time was conducted to determine the diagnostic accuracy and disease pattern of cytokines in HBV infection among a Ghanaian population.
Materials and Method

Study design and site
This cross-sectional case control study was carried out at the Serology and Virology Unit of Komfo Anokye Teaching Hospital (KATH). KATH is a 1000 bed capacity tertiary referral hospital that serves the Kumasi metropolis, surrounding towns and northern sector of Ghana and it is located in Kumasi in the Ashanti region.
Study population and recruitment
Patients with HBV infection or history of HBV infections were selected as cases and healthy blood donors as controls. They were screened for HBsAg profile, HCV and HIV. Those positive with HCV and HIV were excluded. Finally, 120 HBV infected patients and 105 healthy blood donors were recruited as cases and control respectively. Structured questionnaires were used to obtain socio-demographic information of study participants. Information pertaining to clinical care and other conditions were inferred from folders and their hospital biodata.
Inclusion and exclusion criteria
Patients with HBV or past history of HBV were included in the study while those positive for hepatitis C and human immunodeficiency viral, pregnant women, those on herbal medication, coexistence of other chronic liver disease, alcohol consumption and history of immunosuppressive/antiviral therapy were excluded from the study. 
Ethical consideration
Classification of HBV infections
HBV infections were classified as acute infection, HBV recovery, HBeAg positive CHB and HBeAg negative CHB as described by Krajden et al. (2005) and (Shepard et al., 2006) 
Statistical analysis
Data was entered into excel worksheet (Microsoft Office, 2013 version) and was analysed using GraphPad Prism version 6.01 (GraphPad Software, Inc., CA, USA). Data was expressed as mean ± SD, median (inter quartile range) and frequency (proportion) where appropriate. Kruskal-Wallis test followed by Dunn's multiple comparisons test were used to analyse the various stages of HBV infection and control. Area under the curve (AUC) and receiver operating characteristic (ROC) were used to determine diagnostic accuracy of the various cytokines. P value of <0.05 was considered significant 
Results
Figure 6. IL-6 concentration in the various stages of HBV infection
Median levels of IL-6 were elevated in acute infection, HBV recovery and in HBeAg negative CHB groups but reduced in HBeAg positive CHB compared to control group (p=0.0702) (Figure 6 ). Table 3 summarize the diagnostic capacities of the various cytokines in acute HBV infection and HBV recovery. In the acute infection group, IL-10 had an AUC of 0.71 and at a threshold of >15pg/ml and at 95% confidence interval had a sensitivity of 66.7% the highest specificity of 86.7% which was significantly different from those of IL-12p70,TNF-α, IFN-γ and IL-6. Although IL-6 had the highest AUC 0.774(95% CI, 0.630 to 0.882), it was not significantly different from other cytokines. In the HBV recovery group, IL-4 had the highest AUC of 0.716and at a threshold value of >37.5pg/ml and 95% confidence interval had a sensitivity of 66.7% and a specificity of 84.4% which was significantly different from the specificities of IL12p70, TNF-α and IFN-γ. Table 4 summarizes the diagnostic performance of the various Th1 and Th2 cytokines tested in HBeAg positive and HBeAg negative CHB infections. In the HBeAg positive CHB, IL-6 had an AUC of 0.75 which at 95% confidence interval was significantly different from that of IFN-γ. At a threshold value of ≤30pg/mL, IL-6 had a sensitivity of 80% and the highest specificity of 71.1% and was statistically different from that of INF-γ but similar to all the other cytokines.
In HBeAg negative CHB,IL-10 had the highest AUC of 0.66, its sensitivity of 67.0%, specificity of 60.0%, PPV of 78.8%, NPV of 45.0% at a threshold of >4.8 pg/ml. Taken together, IL-10 was the best marker for HBeAg negative CHB although IL-6 had similar AUC, sensitivity and specificity of 0.53, 43% and 73.3% respectively. 
Discussion
This study explored the disease pattern of immunosuppressive, Th1 and Th2 cytokines and their diagnostic accuracy in identifying the various stage of HBV infections among a Ghanaian population. IL-4 was significantly elevated in both HBV recovery and HBeAg negative CHB whilst IL-10 was significantly elevated in HBeAg negative CHB compared to controls. For the first time, we identified IL-4 as the most specific and sensitive marker for identifying HBV recovery infection, IL-6 as the most specific and accurate diagnostic marker for identifying HBeAg positive CHB and IL-10 was identified as the most accurate, sensitive and specific for identifying both acute HBV infections and HBeAg negative CHB. Levels of IL-12p70, and TNF-α were elevated in HBeAg positive chronic infection and IFN-γ in HBeAg negative CHB but showed no significant difference compared to controls.
This study found a significantly increased concentration of IL-4 among participants with HBV recovery and HBeAg negative CHB (Table  3) .The significant increase in IL-4 among HBV recovery group is consistent with a case-control study by Benhamou (2004) among Italian population. He et al. (2013) and Falasca et al. (2006) also observed a significant elevation in IL-4 among CHB infections which is in agreement with the present study. Increased concentration of IL-4 have been shown to suppress HBsAg mRNA, the pregenomic RNA and the precore mRNA which secrets the HBeAg (Lin et al., 2003) . This may lead to sero-clearance of HBsAg and HBeAg and subsequently sero-conversion to HBsAb and HBeAb respectively.
This study also observed a reduced IL-10 levels among participant who had recovered from HBV infection but elevated in acute infections, HBeAg positive CHB and significantly in HBeAg negative CHB compared to controls. The significant elevation in IL-10 among participants with HBeAg negative CHB is consistent with findings by Khan et al. (2011) and Falasca et al. (2006) . IL-10 has immune-regulatory properties able to inhibit the secretion of Th1 cytokines and suppressing cellular immune response to HBV thus shifting the balance towards a Th2 type profile which favours persistent or chronic infection (Asadullah et al., 2003; Das et al., 2012) .
Although IL-12p70 levels were elevated in acute infection, HBeAg positive and HBeAg negative CHB infections but reduced in HBV recovery compared to control there was no statistical significant difference (Table 3) . Similarly, no statistical significant difference was observed for the increase in TNF-α concentration among participants with acute infection, HBeAg positive and HBeAg negative CHB infections as well as a reduction in concentration among those with recovery HBV infection compared to controls (Table 3 ). Our study also observed an increase in IFN-γ concentration among participants with HBeAg positive and HBeAg negative CHB though not statistical significantly different from the control group (Table 3) . Furthermore, a reduced concentration of IL-6 was observed among participants with acute HBV infection though elevated levels were observed in HBV recovery, HBeAg positive and HBeAg negative CHB compared to controls with no statistically significant difference (Table 3) .
At a threshold point of >37.5pg/ml with specificity of 84.4%, sensitivity of 66.67%, PPV of 53.3%, NPV of 90.5%, and AUC of 0.72, IL-4 was identified as the most specific and sensitive marker for HBV recovery (Table 4) . Th2 cytokine like IL-4 are able to stimulate B cell culminating in an increase production of hepatitis B antibodies. This buttresses its role in the pathogenesis of recovery infection. Increase level of IL-6 cytokine in chronic HBV infection have been shown to inhibit Hepatitis B viral replication and also probable in predictor of hepatocellular carcinoma (Porta et al., 2008; Kuo et al., 2009) . In this study IL-6 was identified as better specific and accurate marker with a sensitivity of 80.0%, specificity of 71.1%, PPV of 23.5%, NPV of 96.9% and a threshold point of ≤30pg/ml for HBeAg positive CHB infection (Table 5) .The most specific, sensitive and accurate cytokine for acute infections was IL-10 as depicted by a sensitivity of 66.7%, specificity of 86.7%, PPV of 25.0%, NPV of 97.5%, AUC of 0.72 and a threshold of >15pg/ml (Table 4) . At a threshold of >4.8 pg/ml and a sensitivity of 67.0%, specificity of 60.0%, PPV of 78.8%, NPV of 45.0% and AUC of 0.66, IL-10 was identified as a better marker for HBeAg negative CHB infection (Table 5 ).
The limitation of the current study is our inability to get equal number of participants in various classification of HBV infection. We therefore recommend increasing the number of study participants proportionally in these various groups of HBV in future studies. 
Conclusion
IL-10 was identified as the best diagnostic marker for identifying acute HBV and HBeAg negative CHB, IL-4 the best diagnostic marker for identifying HBV recovery and IL-6 the best marker for identifying HBeAg positive CHB. The correlation of these cytokines to the various stage of HBV infections highlights the critical role of these molecules in the pathogenesis of HBV from infection. This may ultimately lead to improvements in the clinical management of HBV infection patients based on the diagnostic value of defined cytokine profiles.
